Drug Type Small molecule drug |
Synonyms CP-161242 |
Target |
Action partial agonists |
Mechanism 5-HT1D receptor partial agonists(Serotonin 1d (5-HT1d) receptor partial agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC22H21N5 |
InChIKeyKVKYGVOAHGNAKZ-QGZVFWFLSA-N |
CAS Registry160906-61-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anxiety Disorders | Discovery | United States | - | |
| Depressive Disorder | Discovery | United States | - | |
| Migraine Disorders | Discovery | United States | - |





